No Data
No Data
Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely?
Champions Oncology Cut to Hold From Buy by Craig-Hallum
Champions Oncology Cut to Hold From Buy by Craig-Hallum
Express News | Craig-Hallum Downgrades Champions Oncology to Hold
Champions Oncology Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/13/2024 — Craig-Hallum Downgrades Buy → Hold 09/22/2023 32.74% Roth MKM $9 → $7.5 Maintains Buy 03/15/
Earnings Call Summary | Champions Oncology(CSBR.US) Q3 2024 Earnings Conference
The following is a summary of the Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript:Financial Performance:Champions Oncology reported Q3 revenue of $12 million, a 6% decline compared to
Champions Oncology: Q3 Earnings Insights
Champions Oncology (NASDAQ:CSBR) reported its Q3 earnings results on Tuesday, March 12, 2024 at 04:00 PM.Here's what investors need to know about the announcement.EarningsChampions Oncology missed est